Multiplex lateral flow assay for simultaneous detection of COVID-19 and influenza A and B antigens. Allows differentiation of respiratory pathogens in a single test.
Manufactured by
Nanjing, Jiangsu, China
Jiangsu Medomics Medical Technology Co., Ltd., founded in October 2017, is located at Biotech and Pharmaceutical Valley of the National Jiangbei New Area, Nanjing, Jiangsu Province. It is an international high-tech enterprise driven by innovation in the area of medical devices R D, production and sales. Medomics focuses on diagnosis of microorganisms, tumors and some rare diseases, mainly engaged in the research and development, production and sales of in vitro diagnostic reagents and automatic instruments. Medomics owns two R D centers in China and the US, independent intellectual property rights of fluorescent staining technology, protein labeling technology, time-resolved immunofluorescence detection technology, image processing and analysis technology and other innovative technology platforms, as well as a total of more than 2,000 square meters of GMP purification production workshop that meets the product standards of FDA, CE and CFDA. Medomics also has a multidisciplinary expert team with abundant experience in the industry, including senior experts in immunology, microbiology, applied physics, polymer materials, medical imaging, optical systems, etc. The members of the technical team are led by doctors from many famous institutions, such as Osaka University, North Carolina University, University of Nebraska Lincoln, Zhejiang University, Sichuan University and other institutions. At the very beginning of COVID-19 on early 2020, Medomics developed IgM/IgG antibody detecting kit with the team of Zhong Nanshang. And Medomics published the first research paper on international journal together with State Key Laboratory of Respiratory Disease (National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health). The detecting kit was validated by CDC, Harvard Medical School and Columbia University Irving Medical Center etc. Until May 2020, the kit has been exported to dozens of countries and areas, making great help against SARS-Cov-2. At present, Medomics s series products of SARS-Cov-2 detection have been developed according to ISO 13485 Quality System and European CE Certification.
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
Beijing Jinwofu Bioengineering Technology Co.,Ltd.
China · 4 relevant products
Hangzhou AllTest Biotech Co.,Ltd
China · 9 relevant products
Reagen Inc.
United States · 3 relevant products
SureScreen Diagnostics Limited
United Kingdom · 4 relevant products
Hecin Scientific, Inc.
China · 5 relevant products
Innovita (Tang Shan) Biological Technology Co.,Ltd.
China · 3 relevant products
Xiamen Biotime Biotechnology Co., Ltd.
China · 1 relevant product
Jiangsu Macro & Micro-Test Med-Tech Co., Ltd.
China · 1 relevant product
Lumigenex (Suzhou) Co., Ltd
China · 1 relevant product
Hangzhou Fanttest Biotech Co., Ltd.
China · 3 relevant products
52 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →3 more sourcing countries available
Get free access to all sourcing countries identified for this product.
See all countries →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
12 of 110 closest product alternatives
Beijing Jinwofu Bioengineering Technology Co.,Ltd. · China
A rapid antigen test kit for simultaneous detection of Influenza A, Influenza B, and COVID-19 (SARS-CoV-2). This combo test enables efficient screening for multiple respiratory viruses in a single procedure.
Hangzhou AllTest Biotech Co.,Ltd · China
A rapid antigen test for simultaneous detection of SARS-CoV-2 and Influenza A and B from nasal swab samples. This multiplex test enables quick differentiation between respiratory viral infections in clinical and point-of-care settings.
Reagen Inc. · United States
Combination antigen detection test kit for simultaneous identification of COVID-19, Influenza A, and Influenza B from respiratory samples. Provides rapid differentiation of common respiratory pathogens.
SureScreen Diagnostics Limited · United Kingdom
A combined rapid test cassette for simultaneous detection of SARS-CoV-2 and influenza A/B antigens in a single test.
Hecin Scientific, Inc. · China
A multiplex diagnostic test kit for rapid simultaneous detection of SARS-CoV-2, influenza A, and influenza B antigens. This immunochromatographic test provides comprehensive respiratory pathogen screening for clinical diagnosis.
Innovita (Tang Shan) Biological Technology Co.,Ltd. · China
A multiplexed rapid diagnostic test for the simultaneous detection and differentiation of Influenza A, Influenza B, and SARS-CoV-2 antigens. The test enables comprehensive respiratory pathogen screening in a single assay.
Xiamen Biotime Biotechnology Co., Ltd. · China
Multiplex rapid diagnostic test for simultaneous detection of SARS-CoV-2 antigen and influenza A/B viruses.
Innovita (Tang Shan) Biological Technology Co.,Ltd. · China
A multiplex rapid antigen detection test that simultaneously identifies Influenza A, Influenza B, and SARS-CoV-2 from a single sample. This combo test provides comprehensive respiratory pathogen screening at the point of care.
Jiangsu Macro & Micro-Test Med-Tech Co., Ltd. · China
Rapid molecular detection kit for simultaneous identification of SARS-CoV-2, influenza A, and influenza B viruses. Utilizes isothermal amplification technology for quick diagnostic results.
SureScreen Diagnostics Limited · United Kingdom
A multiplex rapid antigen test simultaneously detecting SARS-CoV-2 and Influenza A/B viruses. Enables differential diagnosis of co-circulating respiratory pathogens in a single test. Results available within minutes for rapid clinical assessment and patient triage.
Hangzhou AllTest Biotech Co.,Ltd · China
A multiplex rapid antigen test for simultaneous detection of SARS-CoV-2, Influenza A+B, and respiratory syncytial virus. This test provides comprehensive assessment for major respiratory viral infections.
Lumigenex (Suzhou) Co., Ltd · China
A rapid test kit for detecting both SARS-CoV-2 and Influenza A+B antigens in patient samples using colloidal gold immunochromatographic technology. The kit provides qualitative results for simultaneous COVID-19 and influenza diagnosis.
98 more product alternatives available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products